Prevention of Epstein-Barr Virus Reactivation With the ATG-based Haploidentical Protocol Combined With Rituximab in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Prospective, Multicenter, Open-Label, Randomized Controlled Clini
18h agoen
From the article
Conditions : EBV Infection After Allogenic HSCT Interventions : Drug: Rituximab (R) Sponsors : Nanfang Hospital, Southern Medical University Not yet recruiting
Continue reading on clinicaltrials.govYou might also wanna read

Donor-derived stem cell memory CAR T cells show enhanced expansion and safety in post-HSCT relapse treatment
This first-in-human study (NCT01087294) investigates donor-derived CD19-CAR T cells for treating B cell malignancies relapsing after allogen
cell.com·8d ago

Crianças curadas da leucemia podem precisar tomar todas as vacinas novamente; estudo explica por quê
Correio 24h·3y ago
Polatuzumab Vedotin Boosts Survival in Relapsed DLBCL
Medscape·9h ago
New antibody shows promise for blocking Epstein-Barr virus linked to cancer and autoimmune disease
Epstein-Barr virus (EBV) is carried by 95% of people, usually lying dormant but linked to serious diseases like multiple sclerosis, lupus, r

Hausse des noyades infantiles : pourquoi les cours de natation dès 1 an sont cruciaux selon les pédiatres
Science et vie·8h ago
The Next Outbreak: Hantavirus, Ebola, and Hospital Readiness
aha.org·15d ago

Comments
Sign in to join the conversation.
No comments yet. Be the first.